Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of **myo-inositol**, **alpha-lactalbumin** (α-lactalbumin), and **folic acid** is an oral supplement primarily used to improve reproductive and metabolic outcomes in women with polycystic ovary syndrome (PCOS), including those with inositol resistance[1][3][4][5]. Myo-inositol is a carbocyclic sugar that acts as a second messenger for insulin and follicle-stimulating hormone, contributing to ovarian function, insulin sensitivity, and metabolic regulation. Alpha-lactalbumin is a whey protein that enhances the intestinal absorption of myo-inositol, reduces inositol resistance, and may exert anti-inflammatory effects. Folic acid supports neural tube development and helps reduce the risk of neural tube defects in pregnancy when used in conjunction with myo-inositol[2]. This combination has been shown to improve ovulation rates, menstrual cycle regularity, metabolic indices (such as HOMA-Index and BMI), and hyperandrogenism in women with PCOS. Clinical studies suggest it is also beneficial for women with infertility associated with PCOS, enhances the chance of desired pregnancy, and supports pregnancy outcomes by reducing the risk of gestational diabetes and pre-eclampsia[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myo-inositol + alpha-lactalbumin + folic acid.